A joint report launched by HealthKois and BCG on Wednesday stated that PE/VC investment into pharma rose 2.1x in five years to $731 million in FY26, and the number of biotech startups grew from roughly 1,500 to 2,400 during the same period.
​A joint report launched by HealthKois and BCG on Wednesday stated that PE/VC investment into pharma rose 2.1x in five years to $731 million in FY26, and the number of biotech startups grew from roughly 1,500 to 2,400 during the same period.  by Soban News (international And National News)
